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Abstract
Platelets are a recognised potent source of transforming growth factor-β1 (TGFβ1), a
cytokine known to promote wound healing and regeneration by stimulating dermal
fibroblast proliferation and extracellular matrix deposition. Platelet lysate has been
advocated as a novel personalised therapeutic to treat persistent wounds, although
the precise platelet-derived growth factors responsible for these beneficial effects
have not been fully elucidated. The aim of this study was to investigate the specific
role of platelet-derived TGFβ1 in cutaneous wound healing. Using a transgenic
mouse with a targeted deletion of TGFβ1 in megakaryocytes and platelets (TGFβ1fl/fl.
PF4-Cre), we show for the first time that platelet-derived TGFβ1 contributes to
epidermal and dermal thickening and cellular turnover after excisional skin wounding.
In vitro studies demonstrate that human dermal fibroblasts stimulated with platelet
lysate containing high levels of platelet-derived TGFβ1 did not exhibit enhanced
collagen deposition or proliferation, suggesting that platelet-derived TGFβ1 is not a
key promoter of these wound healing processes. Interestingly, human keratinocytes
displayed enhanced TGFβ1-driven proliferation in response to platelet lysate,
reminiscent of our in vivo findings. In summary, our novel findings define and
emphasise an important role of platelet-derived TGFβ1 in epidermal remodelling and
regeneration processes during cutaneous wound healing.
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Platelet lysate (PL) or platelet-rich plasma (PRP) has increasingly been
advocated as a novel personalised therapeutic to facilitate tissue
repair and regeneration (Anitua, Pino, & Orive, 2017). PL enhances
migration and wound closure of keratinocytes or dermal fibroblasts
in vitro (Barsotti et al., 2013; Ranzato, Mazzucco, Patrone, & Burlando,
2009). These beneficial effects are presumed to be driven by the high
concentration of platelet-released growth factors such as trans-
forming growth factor-β1 (TGFβ1) and platelet-derived growth factor.
However, these in vitro studies along with a lack of in vivo data do
not address the specific contribution of platelet-derived TGFβ1 in
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tissue repair, and in addition, there are no standardised methods of PL
or PRP preparation (Marques et al., 2015).
To investigate the role of platelet-derived TGFβ1 in cutaneous
wound healing in vivo, we utilised a targeted knockout transgenic
mouse in which megakaryocytes and platelets are depleted of TGFβ1
(TGFβ1fl/fl.PF4-Cre; Labelle, Begum, & Hynes, 2011) in an excisional
wound healing model. Normal platelet counts, clotting times, and gen-
eral physical appearance are reported for these transgenic mice
(Labelle et al., 2011). A significant reduction of platelet-derived active
TGFβ1 in transgenic thrombin-activated PRP compared with litter-
mate controls was confirmed by a TGFβ1 bioassay (Figure 1a). Other
growth factors such as PDGF-BB and VEGF were similar in transgenic
thrombin-activated PRP compared with littermate controls
(Figure S1). After 6 mm2 punch biopsy excisional wounds were
created on the backs of mice, we did not observe any macroscopic
differences in the rate of wound closure over 14 days between litter-
mate controls and TGFβ1fl/fl.PF4-Cre animals. This similarity was also
reflected in wound width as measured in skin tissue harvested at day
F IGURE 1 Platelet-derived transforming growth factor-β1 (TGFβ1) promotes epidermal hyperplasia in a murine skin wound healing model.
(a) Quantification of active TGFβ1 in thrombin activated platelet-rich plasma from TGFβ1fl/fl.PF4-Cre (n = 4) or littermate controls (n = 4) by mink
lung epithelial cell TGFβ1 bioassay. 6 mm2 punch biopsy excisional wounds were made on TGFβ1fl/fl.PF4-Cre or littermate control mice (n = 6 per
group) and skin tissue harvested 14 days later for histological analysis. (b) Wound width was measured from H&E-stained skin tissue. (c–d)
Representative H&E-stained wound site at high magnification and quantification of epidermal and dermal thickness from three sites across the
wound. (e) Low magnification of H&E-stained tissue showing surrounding unwounded skin and wound site (marked above by black line). (f)
Representative modified Martius scarlet blue trichrome-stained (blue = collagen, yellow = red blood cell, red = cytoplasm, dark red = nuclei) and
(g) elastin- and H&E-stained wounds (dark purple/black = elastin, nuclei = black), insert at higher magnification of blood vessels. (h) CD61,
(i) caspase-3 or (j) Ki-67 expression, or (k) staining controls as denoted by red staining. CD61+ platelets and Ki-67+ cells are indicated by arrows.
All image objectives are denoted by the scale bar. Error bars are defined as mean ± standard error of the mean. Any statistical differences using an
unpaired t test or Mann–Whitney U tests are indicated [Colour figure can be viewed at wileyonlinelibrary.com]
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14 after wounding (Figure 1b). This suggests that the loss of platelet-
derived TGFβ1 does not impede the overall healing process. Interest-
ingly, H&E histological analysis of the wound after 14 days revealed
significantly thinner epidermis and dermis in TGFβ1fl/fl.PF4-Cre ani-
mals compared with controls (Figure 1c,d). Dermal and epidermal
layers in unwounded skin surrounding the wound area were similar
between control and TGFβ1fl/fl.PF4-Cre mice (Figure 1e). Also, we did
not observe any significant difference in the number of hair follicles in
the wound site between control and TGFβ1fl/fl.PF4-Cre mice
(Figure S2).
TGFβ1 is a known mediator of collagen and elastin production
from fibroblasts in vitro (Davidson, Zoia, & Liu, 1993). However, modi-
fied Martius scarlet blue trichrome and elastin–H&E staining revealed
no discernible difference in collagen (blue staining) or elastin deposi-
tion (purple staining) at the wound site between control and
TGFβ1fl/fl.PF4-Cre mice (Figure 1f,g), although there was a reduction
in the elastin staining around the skin capillaries in TGFβ1fl/fl.PF4-Cre
mice (Figure 1g insert). This suggests that platelet-derived TGFβ1
does not significantly regulate extracellular matrix deposition in this
model. Furthermore, immunohistochemical analysis showed the pres-
ence of CD61+ cells (a marker for platelets) throughout the dermal
and adipose layers in the wound site (Figure 1h), along with dramati-
cally less caspase-3 and Ki-67 expression in TGFβ1fl/fl.PF4-Cre mice
compared with staining controls (Figure 1i–k). This indicates that
there may be a lower cellular turnover in terms of proliferation and
apoptosis in TGFβ1fl/fl.PF4-Cre mice after wounding.
As TGFβ1 has previously been demonstrated to increase over
time in wounded skin (Ishida, Kondo, Takayasu, Iwakura, &
Mukaida, 2004) and along with our observations of increased
in vivo Ki-67 expression as a marker of cell proliferation, we next
investigated whether platelet-derived TGFβ1 can induce functional
changes in specific dermal cells. PL contains high levels of platelet-
derived active and latent TGFβ1 as quantified by a TGFβ1 bioassay
(Figure 2a). TGFβ1 treatment of dermal fibroblasts for 48 hr led to
F IGURE 2 Platelet-derived
transforming growth factor-β1
(TGFβ1) stimulates epidermal
keratinocyte proliferation. (a) Active
and latent TGFβ1 quantification of
10% foetal bovine serum (FBS)/
Dulbecco's modified eagle's
medium (DMEM) or platelet lysate
(PL; n = 3 donors) by mink lung
epithelial cell TGFβ1 bioassay
(ND = not detected). (b–c)
Representative images and
quantification of normal human
dermal fibroblast (NHDF; n = 2
lines) treated with 1 ng/ml TGFβ1
or 10% PL (n = 3 donors) for 48 hr
without serum; extracellular
collagen I (green) and
40,6-diamidino-2-phenylindole
(blue). NHDF (d) or normal human
epidermal keratinocyte (NHEK)
(e) treated with 10% PL (n = 3
donors), 10% FBS/DMEM, cMedia,
or 1 ng/ml TGFβ1 for 72 hr in an
EdU Click-iT assay. NHEKs were
pretreated with 1μM ALK5
inhibitor (SB-525334) for 30 min
before stimulation. Proliferation
rates as determined by EdU
incorporation were calculated
relative to treatment-matched no
EdU controls. Error bars are defined
as mean ± standard error of the
mean. Any statistical differences
compared with media control were
determined by one- or two-way
analysis of variance [Colour figure
can be viewed at wileyonlinelibrary.
com]
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significant increase in extracellular collagen I deposition in a
concentration-dependent manner (Figure 2b,c; Figure S3) without
affecting cell number compared with media-treated controls, as
quantified by 40,6-diamidino-2-phenylindole staining. Interestingly,
stimulation of dermal fibroblasts with PL did not significantly affect
collagen deposition or cell proliferation as determined by EdU
incorporation (Figure 2c,d). This suggests that growth factors
released from platelets do not have a profound effect on human
dermal fibroblast function in vitro. Primary human keratinocytes
stimulated with complete media or TGFβ1 had increased cell prolif-
eration, and this was also seen with PL treatment (Figure 2e).
TGFβ1- or PL-induced proliferative effects were significantly
decreased when keratinocytes were pretreated with an ALK5 inhib-
itor to block downstream TGFβ1 receptor signalling prior to stimu-
lation with PL (Figure 2e). This suggests that platelet-derived
TGFβ1 significantly contributes to primary human keratinocyte
proliferation.
As far as we are aware, this is the first study where the spe-
cific contribution of platelet-derived TGFβ1 in an excisional wound
healing mouse model has been investigated. Studies investigating
the role of TGFβ1 in excisional wound healing models have pro-
duced conflicting results. TGFβ1 knockout mice exhibited delayed
wound closure with thinner, less vascular granulation tissue
(Brown, Ormsby, Doetschman, & Greenhalgh, 1995), whereas mice
with keratinocytes overexpressing TGFβ1 display delayed rates of
re-epithelisation after wounding (Chan et al., 2002). We did not
witness augmented wound closure or collagen deposition in our
platelet-derived TGFβ1 knockout mice. Perhaps in our model, plate-
lets are not the main source of TGFβ1 in directly mediating wound
closure, and other cell types such as keratinocytes may express this
important growth factor in vivo to mediate these effects (Amjad,
Carachi, & Edward, 2007).
In contrast to other in vitro studies (Ranzato et al., 2009), we
did not observe any differences in proliferation or collagen deposi-
tion when human dermal fibroblasts were stimulated with PL, even
at varying dilutions of PL and time points (Figure S4). This discrep-
ancy may be due to the choice of methodology to measure prolif-
eration (i.e., nuclear crystal violet staining or measuring
mitochondrial metabolism compared to EdU incorporation into
DNA). Our result of enhanced proliferation of TGFβ1-stimulated
human keratinocytes is novel and differs from other studies
(Dahler, Cavanagh, & Saunders, 2001). The discrepancy may reflect
differential effects of TGFβ1 dependent on cell-cycle stage
(Alexandrow & Moses, 1995), the amount of TGFβ1 used (10 ng/ml
in contrast to our 1 ng/ml), and experimental endpoints (48 vs. our
72 hr). However, TGFβ1 has pleotropic effects and others have
shown αv integrin-activated latent TGFβ1 to increase keratinocyte
growth and wound healing in vivo (Duperret, Natale, Monteleon,
Dahal, & Ridky, 2016), through ALK-5-dependent induction of
keratinocyte miRNA-132 expression, lending support to our in vitro
results (Li et al., 2015). Interestingly, TGFβ1 signalling blockade in
keratinocytes resulted in decreased proliferative response to
PL. These are novel findings as the relative contribution of
platelet-derived TGFβ1 on dermal fibroblasts and keratinocytes has
never been specially studied in vitro. These results also mirrored
our in vivo mouse data in which we demonstrated increased Ki-67
staining in control wounded skin, particularly in the epidermal
layers, rich in keratinocytes. Less Ki-67 staining was observed in
TGFβ1fl/fl.PF4-Cre animals, suggesting that platelet-derived TGFβ1
contributes to proliferation of keratinocytes and aids epidermal
remodelling.
Of interest, the striking in vivo phenotype observed in our study
is reminiscent of aged skin consisting of thinner epidermis
(Bhattacharyya, 2004). Although our transgenic animals are not a skin
aging model, it has been shown that platelet-derived mediators such
as TGFβ1 are lower in older individuals (Evanson et al., 2014),
suggesting that a loss in platelet-derived TGFβ1 with age may contrib-
ute to the histological changes of skin aging.
In conclusion, we have observed a novel role for platelet-derived
TGFβ1 in skin wound healing. Although platelet-derived TGF1β does
not directly enhance the rate of wound closure, it appears to signifi-
cantly promote keratinocyte proliferation and epidermal layer
remodelling and regeneration, and this insightful observation adds to
and refines our current understanding of the normal cutaneous
wound healing process.
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Figure S1 Quantification of PDGF-BB and VEGF in thrombin acti-
vated PRP from TGFβ1fl/fl.PF4-Cre (n = 4) or littermate controls
(n = 4) by ELISA. Error bars are defined as mean ± SEM. No significant
differences were found using a Mann Whitney U test.
Figure S2 6mm2 punch biopsy excisional wounds were made on
TGFβ1fl/fl.PF4-Cre or littermate control mice (n = 6/group) and skin
tissue harvested 14 days later for histological analysis. The number of
hair follicles in the wound site were counted on H&E stained sections.
Error bars are defined as mean ± SEM. No significant different was
found using a student t-test.
Figure S3 NHDFs were treated with varying TGFβ1 concentrations
for 48 h and extracellular collagen deposition and total cell number
were quantified by immunofluorescent staining. Error bars are defined
as mean ± SEM. Any significant differences were determined by
1-way ANOVA compared to the media control and indicated above.
Figure S4 NHDFs were treated with varying PL amounts, 10% FBS
(positive control) or media (negative control) for 24, 48 or 72 h. Cell
proliferation were quantified by an EdU incorporation Click-iT assay.
Error bars are defined as mean ± SEM. Any significant differences
were determined by 1-way ANOVA compared to the time-matched
media control and indicated above.
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